NEWS
Two left in running for Healthscope hospital properties
MELBOURNE: The sale of a $1.2bn portfolio of Healthscope hospital properties is understood to have… read more
Neuren drug finally been cleared by FDA in USA
SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US… read more
12 new senior healthcare executives sought for key roles
MELBOURNE: Twelve senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
